• OPEN AN ACCOUNT
Indian Indices
Sensex
76,816.14 -448.37
( -0.58%)
Global Indices
Nasdaq
53,569.16 -21.28
(-0.04%)
Dow Jones
7,731.77 -20.22
(-0.26%)
Hang Seng
66,369.62 237.64
(0.36%)
Nikkei 225
10,816.31 23.77
(0.22%)
Forex
USD-INR
95.48 0.22
(0.23%)
EUR-INR
111.24 0.16
(0.15%)
GBP-INR
129.74 0.04
(0.03%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
337.9869392
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
44.15
44472.92
EPS(TTM)
Face Value()
Div & Yield %
80.61
2
0.79
 

avenuesai ltd
Can Fin Homes board approved fund raising up to Rs 5,000 cr via debt issuance
Jun 08,2026
The board of Can Fin Homes at its meeting held on 08 June 2026 has approved fund raising up to Rs 5,000 crore by way of issuance of on-shore and/or off-shore debt instruments including but not limited to bonds, non-convertible debentures, non-convertible subordinated debt in the nature of Tier II NCDs/bonds, Residential Mortgage Backed Securities (RMBS) including Pass Through Certificates (PTC) denominated in Indian currency and/or any foreign currency.